Patenting in stem cell research
Other Current topics
1. IPR and the EC Framework Programme
2. The "Community Patent"; issues of concern for the scientific community
3. The "Digital Agenda" and IPR issues
4. Patenting in stem cell research
New! ALLEA Statement on Patenting of Inventions Involving Human Embryonic Pluripotent Stem Cells in Europe
4.1. Background material 
Decision of the Enlarged Board of Appeal of the the European Patent Office, dated 25 November 2008 (G 2/06) Regulation(EC) No 1394/2007 of the European Parliamant and the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004
q Legal protection of biotechnological inventions
q Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions
q Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells
q Opinion of Advocate General Bot, delivered on 10 March 2011 (1): Case C 34/10 Oliver Brüstle v Greenpeace eV [Reference for a preliminary ruling from Bundesgerichtshof (Germany)] (Directive 98/44/EC – Legal protection of biotechnological inventions) Presentation Joseph Straus; Does Stem Cell Research in Europe Use Human Embryos for Industrial or Commercial Purposes? ALLEA Symposium on Intellectual Property Rights in the European Research Area: Grand Challenges and New Opportunities, Hungarian Patent Office, World Science Forum, Budapest (HU), 4 November 2009 Article J. Straus, Zur Patentierung humaner embryonaler Stammzellen in Europa, GRUR, 11/2010
q EuroStemCell ESF-Science Policy Briefing 38 Human Stem Cell Research and Regenerative Medicine, May 2010
q German Reference Center for Research in the Life Sciences